Li Ka Shing Foundation Report issue

Foundation

Organization Overview

First Clinical Trial
2007
NCT00493363
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2007

Timeline

NOW
  • Now

Active Ingredients

Drugs in Other Trials (2)

artesunate (1 trial)

mefloquine (lariam) (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 1
  • # of Trial APIs: 2